As of March 23, 2026, Bionano Genomics's top three insider holders are Soheil Shams (Chief Informatics Officer, 5.33Mn shares), Christopher P. Stewart (Chief Financial Officer, 281.37K shares), Hannah Mamuszka (Director, 65.79K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Soheil Shams | Chief Informatics Officer | 5,325,378 | 0 | 20 Oct, 2021 |
| Christopher P. Stewart | Chief Financial Officer | 281,373 | 0 | 16 May, 2023 |
| Hannah Mamuszka | 65,789 | 0 | 14 Jun, 2023 | |
| Gulsen Kama | Chief Financial Officer | 16,000 | 0 | 05 Jun, 2024 |
| R. Erik Holmlin | President And Ceo | 0 | 5,025 | 30 Nov, 2021 |
| R. Erik Holmlin | President And Ceo | 1,657 | 0 | 18 Feb, 2026 |
| Mark Oldakowski | Chief Operating Officer | 895 | 0 | 18 Feb, 2026 |
| Alka Chaubey | Chief Medical Officer | 644 | 0 | 18 Feb, 2026 |
| Jonathan V. Dixon | General Counsel | 263 | 0 | 18 Feb, 2026 |
| Mark Adamchak | Principal Accounting Officer | 260 | 0 | 18 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Feb, 2026 | Jonathan V. Dixon | Common Stock | D | 6 | $1.10 | 263 | D | F |
| 17 Feb, 2026 | R. Erik Holmlin | Common Stock | D | 51 | $1.10 | 1,657 | D | F |
| 17 Feb, 2026 | Alka Chaubey | Common Stock | D | 18 | $1.10 | 644 | D | F |
| 17 Feb, 2026 | Mark Adamchak | Common Stock | D | 3 | $1.10 | 260 | D | F |
| 17 Feb, 2026 | Mark Oldakowski | Common Stock | D | 20 | $1.10 | 895 | D | F |
| 02 Feb, 2026 | R. Erik Holmlin | Stock Option (Right to Buy) | A | 69,484 | $0.00 | 69,484 | D | A |
| 02 Feb, 2026 | Alka Chaubey | Stock Option (Right to Buy) | A | 27,737 | $0.00 | 27,737 | D | A |
| 02 Feb, 2026 | Mark Adamchak | Stock Option (Right to Buy) | A | 10,890 | $0.00 | 10,890 | D | A |
| 02 Feb, 2026 | Mark Oldakowski | Stock Option (Right to Buy) | A | 27,737 | $0.00 | 27,737 | D | A |
| 02 Feb, 2026 | Jonathan V. Dixon | Stock Option (Right to Buy) | A | 26,117 | $0.00 | 26,117 | D | A |
| 11 Sep, 2025 | Mark Oldakowski | Common Stock | D | 59 | $4.06 | 915 | D | F |
| 11 Sep, 2025 | Alka Chaubey | Common Stock | D | 51 | $4.06 | 662 | D | F |
| 11 Jun, 2025 | Christopher J Twomey | Stock Option (Right to Buy) | A | 2,775 | $0.00 | 2,775 | D | A |
| 11 Jun, 2025 | Albert Luderer | Stock Option (Right to Buy) | A | 2,775 | $0.00 | 2,775 | D | A |
| 11 Jun, 2025 | Yvonne Linney | Stock Option (Right to Buy) | A | 2,775 | $0.00 | 2,775 | D | A |
| 11 Jun, 2025 | Aleksandar Rajkovic | Stock Option (Right to Buy) | A | 2,775 | $0.00 | 2,775 | D | A |
| 11 Jun, 2025 | Kristiina Md Vuori | Stock Option (Right to Buy) | A | 2,775 | $0.00 | 2,775 | D | A |
| 11 Jun, 2025 | Hannah Mamuszka | Stock Option (Right to Buy) | A | 2,775 | $0.00 | 2,775 | D | A |
| 03 Jun, 2025 | Mark Oldakowski | Common Stock | D | 27 | $3.69 | 974 | D | F |
| 03 Jun, 2025 | Jonathan V. Dixon | Common Stock | D | 25 | $3.69 | 269 | D | F |